AdvaMed lobbyist JC Scott to succeed Mark Merritt, who is leaving after 15 years pharmacy benefit managers group
Sept. 28, 2017
By Walt Williams
Lobbyist JC Scott will become the next CEO of the Pharmaceutical Care Management Association following the departure of Mark Merritt, who has led the $21 million-revenue group for 15 years.
Scott currently is chief advocacy officer and head of external affairs for the Advanced Medical Technology Association. He will begin his new role as PCMA’s chief executive Oct. 15, leading a group embroiled in policy fights on drug pricing and, more recently, the opioid crisis.
“JC is an exceptional choice with a tremendous record of accomplishments, both in the regulatory sphere as well as legislatively,” PCMA Board Chairman Tim Wentworth said in a statement. “He has the policy depth and acumen in federal and state advocacy that will serve our association and industry well, and set us on new paths of success moving forward.”